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Introduction
Melanoma is a rare type of paediatric malignancy with an inci-
dence of fewer than 500 cases being diagnosed annually in the 
United States.1 The distinction of malignant Spitz lesions from 
the typically benign Spitz nevi is critical for prognosis and 
clinical management of paediatric patients. However, it can be 
difficult to distinguish these based solely on conventional his-
tologic features because of morphologic heterogeneity, with 
poor diagnostic concordance among clinicians.2,3
In contrast with benign Spitz Nevi, approximately 96% of 
melanomas have chromosomal copy number gains and 
losses.4 Therefore, array comparative genomic hybridization 
(CGH) can aid classification of melanocytic lesions, espe-
cially when diagnosis based on histology is inconclusive.5,6
To the best of our knowledge, there is a limited number of 
reports demonstrating CGH analysis in diagnosing mela-
noma in children aged 5 and younger.5,7 We report a case of 
invasive melanoma in a 5-year-old Canadian male whose 
genomic profile was assessed by array comparative genomic 
hybridization (aCGH).
Case report
A 5-year-old Caucasian male with Fitzpatrick skin type 2 
was referred for evaluation of a lesion along the midline of 
his upper back. The lesion was first noted at 2 years of age. It 
later developed as a 6 mm brown papule, which was diag-
nosed as a nevus, with a peripheral halo of hypopigmenta-
tion and central thickening (Figure 1). There was no family 
history of melanoma.
An excisional biopsy (9 mm by 6 mm by 3 mm) was per-
formed. The junctional component of the nevus was relatively 
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symmetric and contained large melanocytes with abundant 
cytoplasm and nucleoli. In the epidermis, melanocytes were 
distributed primarily as nests at the tips and sides of the rete 
ridges with some clefting from the overlying epidermis and 
discohesion among melanocytes within the nests (Figure 
2(a)). Nests appeared to predominate over single cells, with-
out a significant upwards scatter (Figure 2(b) and (c)). Single 
cells were plump epithelioid cells with amphophilic to eosino-
philic cytoplasm and nuclei. Some had prominent nucleoli, 
and others had marked nuclear hyperchromasia and smudg-
ing. In the dermis, similar melanocytes were present with poor 
maturation upon descent. Kamino bodies were not observable. 
The dermal component also revealed prominent nuclear atypia 
with scattered mitotic figures (Figure 2(d)). Asymmetrical 
melanin pigmentation of the dermal component and a mild, 
asymmetric lymphocytic infiltrate were noted. A small cluster 
of melanocytes with cytomorphology suggestive of a conven-
tional nevus component was also present.
Immunohistochemistry showed a loss of p16 through-
out the lesion, except in the region of the conventional 
nevus component. HMB45 revealed faint positivity 
Figure 1. The pigmented lesion with a peripheral halo of 
hypopigmentation. Within the previous year prior to referral, it 
had started to enlarge and thicken centrally with no associated 
pruritus or pain.
Figure 2. Hematoxylin and eosin stain of the biopsy. Low power 20x magnification (a) revealed a compound melanocytic proliferation 
involving the base of the epidermis and superficial dermis. The melanocytic proliferation was symmetrical. An inflammatory response 
was not identified. At 40x magnification, (b) most of the epidermal melanocytes were confined to the epidermal base. There was only 
focal intra-epidermal ascent of the melanocytes identified. At 100x magnification, (c) there was no intra-epidermal ascent of melanocytes 
identified in this photograph. The dermal melanocytes showed maturation to the base of the lesions. At 400x, (d) some of the melanocytes 
were multinucleate and exhibited pleomorphism of nuclear size variation (>4x variation). Occasional nucleoli and mitoses were identified.
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throughout the thickness of the lesion. MelanA/Ki67 was 
unable to be interpreted due to poor MelanA staining 
quality.
Due to the atypical features, the specimen was sent out 
for further molecular investigations. aCGH demonstrated 
gain in chromosome 7p, subthreshold gain in chromosome 
7q, loss in chromosome 9, and subthreshold loss in 8p 
(Figure 3). The loss of chromosome 9 was the most promi-
nent molecular result and directly correlated with the loss of 
p16 expression demonstrated by immunohistochemistry 
(Figure 3(d)).6
The patient then underwent wide local excision with 1 cm 
margins. Pathology of the wide local excision tissue showed 
a focal area of dermal fibrosis at the presumed previous 
biopsy site and some reactive, overlying melanocytic cells. 
However, there were no definitive atypical melanocytic cells 
and no evidence of residual malignant melanoma. Sentinel 
lymph node biopsy (SLNB) showed no evidence of meta-
static malignant melanoma. The final diagnosis was an inva-
sive melanoma, non-ulcerated, 1.2 mm Breslow thickness, 
mitotic index 1/mm2, Clark’s level unspecified, and Stage 
IB. The patient remains well 20 months after diagnosis and 
receives regular follow-up.
Discussion
This case highlights the diagnostic challenge of atypical 
Spitz lesions. The patient’s young age and lack of family his-
tory reduced the suspicion of malignant melanoma. However, 
due to the lesion’s evolution, further investigations were 
warranted.
Currently, histopathology is the standard for the diagnos-
tic classification of melanocytic skin lesions. However, there 
is significant inter-observer variability, and no single feature 
or set of criteria are diagnostic.8
In this case, the non-ulcerated lesion shared morphologi-
cal features (melanocytes with abundant cytoplasm and rela-
tively symmetric large nuclei) in keeping with benign or 
intermediate etiologies. However, the presence of nuclear 
atypia in the dermis and melanocytes with mitotic figures 
and poor maturation with descent were worrisome for malig-
nancy. Thus, there was a need to implement diagnostic tools 
such as immunohistochemistry and aCGH to better charac-
terize the lesion. A panel of immunohistochemical markers 
such as Ki-67, HMB45, p53, p16, p21, cyclin D1, and CD99 
can complement conventional histopathology to distinguish 
melanomas from atypical Spitzoid lesions, although diag-
nostic uncertainty may remain.9,10
Figure 3. (a) aCGH analysis of the lesion. There was a gain in chromosome 7p (B), (b) subthreshold gain in chromosome 7q, (c) 
subthreshold loss in 8p, and (d) loss in chromosome 9.
4 SAGE Open Medical Case Reports
The main benefit of CGH is that it can investigate the 
entire genome. The relative abundancies of DNA from 
tumour specimens and normal controls after hybridization 
are compared to determine chromosomal aberrations, repre-
sented by DNA copy number gains or losses.11,12 Bastian 
et al.4 have reported that less than 4% of all malignant mela-
noma studied had a normal CGH result. For our patient, the 
identification of multiple copy number gains and loss, such 
as chromosome 9 loss, indicated genomic instability that 
provided support for the diagnosis of melanoma ex melano-
cytic nevus.
At present, aCGH application in a clinical setting is lim-
ited, especially in the paediatric population. Previously, it 
has been used to confirm the histological diagnosis of a 
benign nodule developing within a congenital melanocytic 
nevus of a 3-month-old infant.7 Vanison et al.13 demonstrated 
its potential to amend a diagnosis of a compound melano-
cytic nevus in a 13-year-old patient. They suggested that ear-
lier application of aCGH could avoid unnecessary surgical 
interventions such as SLNB and complete lymph node dis-
section.13 Tom et al.5 presented their experience of managing 
six paediatric cases of atypical Spitzoid nevi with diagnostic 
modalities including SLNB, immunostaining, and molecular 
analysis. A more recent study by Dubruc et al.14 reported the 
use of aCGH and fluorescence in situ hybridization to reveal 
NRAS gene amplification in two atypical cutaneous melano-
cytic tumours.
In summary, our case highlighted the complexity of diag-
nosing an atypical Spitzoid lesions in young patients. We 
report that aCGH results corroborated with immunohisto-
chemistry and demonstrate that these two adjunctive ana-
lytic methods can further support or refute the diagnosis of 
malignant melanoma.
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